Skip to main content

Chronic Medications and Maxillofacial Surgery

  • Chapter
  • First Online:
  • 1425 Accesses

Abstract

The decision to continue or stop using chronic medication is maybe controversial, and it is important to understand the current guidelines utilizing evidence-based medicine. The controversy lies within the limited evidence regarding many medications and the importance of strategizing medication management on an individual basis. Much of what we do is in the gray zone. The more complicated patients take many medications. As patient’ disease states change, this influences when, where, and how a surgery is planned and how medications are administered. We have put a “bottom line” at the beginning of each section to facilitate a quick decision when necessary.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Engelhard K. Anaesthetic techniques to prevent perioperative stroke. Curr Opin Anesthesiol. 2013;26(3):368–74.

    Article  CAS  Google Scholar 

  2. Fleisher LA, Fleischmann KE, et al. ACC/AHA guideline on perioperative cardiovascular evaluation and Management of Patients Undergoing Noncardiac Surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;130:e278–333.

    Article  PubMed  Google Scholar 

  3. Fleischmann KE, Beckman JA, et al. 2009 ACCF/AHA focused update on perioperative Beta blockade: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. JACC. 2009;54(22):2102–28.

    Article  PubMed  Google Scholar 

  4. January CT, Wann SL, et al. Clinical practice guideline: 2014 AHA/ACA/HRS guideline for the Management of Patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:2246–80.

    Article  Google Scholar 

  5. Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. N Engl J Med. 1984;310(24):1570.

    Article  CAS  PubMed  Google Scholar 

  6. Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative β-blockade and postoperative mortality. Anesthesiology. 2010;113:794–805.

    Article  CAS  PubMed  Google Scholar 

  7. POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371(9627):1839.

    Article  CAS  Google Scholar 

  8. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomized controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100(6):456.

    Article  PubMed  Google Scholar 

  9. Devereaux PJ, Sessler DI, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014;370(16):1504.

    Article  CAS  PubMed  Google Scholar 

  10. Hart GR, Anderson RJ. Withdrawal syndromes and the cessation of antihypertensive therapy. Arch Intern Med. 1981;141(9):1125–7.

    Article  CAS  PubMed  Google Scholar 

  11. Bruce DL, Croley TF, Lee JS. Preoperative clonidine withdrawal syndrome. Anesthesiology. 1979;51(1):90.

    Article  CAS  PubMed  Google Scholar 

  12. Wijeysundera DN, Beattie WS. Calcium channel blocker for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg. 2003;97(3):634.

    Article  CAS  PubMed  Google Scholar 

  13. Wijeysundera DN, Beattie WS, Rao V, et al. Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg. 2004;127(3):755–62.

    Article  CAS  PubMed  Google Scholar 

  14. Smith I, Jackson I. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia? Curr Opin Anesthesiol. 2010;23:687–90.

    Article  Google Scholar 

  15. Kizer JR, Kimmel SE. Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards. Arch Intern Med. 2001;161(9):1145.

    Article  CAS  PubMed  Google Scholar 

  16. Grodecki-De Franco P, Steinhubl S, Taylor P, et al. Calcium antagonist use and perioperative bleeding complications: an analysis of 5,157 patients [abstract]. Circulation. 1996;94(suppl):I–476.

    Google Scholar 

  17. Mohr JP, Orgogozo JM, Harrison MJG, et al. Meta-analysis of oral nimodipine trials in acute ischemic stroke. Cerebrovasc Dis. 1994;4:197–203.

    Article  Google Scholar 

  18. Kheterpal S, Khodaparast O, Shanks A, O’Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combine with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:180–6.

    Article  CAS  PubMed  Google Scholar 

  19. Mets B. To stop or not? Anesth Analg. 2015;120(6):1413–9.

    Article  PubMed  Google Scholar 

  20. Miceli A, Capoun R, FIno C, Narayan P, et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2009;54:1778–84.

    Article  CAS  PubMed  Google Scholar 

  21. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth. 2010;57:736–44.

    Article  PubMed  Google Scholar 

  22. Roshanov P, Rochwerg B, Patel A, Salehian O, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN Propective cohort. Anesthesiology. 2017;126:16–27. Article in Press Accessed 18 Nov 19.

    Article  CAS  PubMed  Google Scholar 

  23. London MJ. Perioperative Administration of Angiotensin-Converting Enzyme Inhibitors or angiotensin II receptor blockers: do we have enough “VISION” to stop it? Anesthesiology. 2017;126(1):1–3. Article in Press Accessed 18 Nov 16.

    Article  PubMed  Google Scholar 

  24. Turan A, You J, Shiba A, Kurz A, Saager L, Sessler DI. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg. 2012;114:552–60.

    Article  CAS  PubMed  Google Scholar 

  25. Drenger B, Fontes ML, Mioa Y, et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation. 2012;126(3):261.

    Article  CAS  PubMed  Google Scholar 

  26. Tagawa M, Ogata A, Hamano T. Pre- and/or intra-operative prescription of diuretics, but not renin-angiotensin-system inhibitors, is significantly associated with acute kidney injury after non-cardiac surgery: a retrospective cohort study. PLoS One. 2015;10(7):e0132507.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Yacoub R, Patel N, Lohr JW, Rajagopalan S, Nader N, Arora P. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies. Am J Kidney Dis. 2013;62:1077–86.

    Article  PubMed  Google Scholar 

  28. Wolf A, McGoldrick KE. Cardiovascular Pharmacotherapeutic considerations in patients undergoing anesthesia. Cardiol Rev. 2011;19(1):12–6.

    Article  PubMed  Google Scholar 

  29. Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(19):2008–24.

    Article  PubMed  Google Scholar 

  30. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23):III39–43.

    PubMed  Google Scholar 

  31. Xian-Yu JB, Feng JF, Chen YC, Yang YW. Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases. Int J Clin Exp Med. 2015;8(8):13983–9.

    PubMed  PubMed Central  Google Scholar 

  32. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systemic review of controlled studies. BMJ. 2006;333(7579):1149. Epub 2006 Nov 6 Accessed on 15 Nov 16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361(10):980.

    Article  CAS  PubMed  Google Scholar 

  34. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg. 2009;249(6):921.

    Article  PubMed  Google Scholar 

  35. Durazzo AE, Machado FS, Ilkeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967.

    Article  PubMed  Google Scholar 

  36. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932.

    Article  CAS  PubMed  Google Scholar 

  37. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J, Clergue F. Perioperative medical management of patients with COPD. Int J Chron Obsrtuc Pulmon Dis. 2007;2(4):493–515.

    Google Scholar 

  38. Cm H, Galvango SM Jr. Patients with chronic pulmonary disease. Med Clin North Am. 2013;97(6):1095–107.

    Article  Google Scholar 

  39. Woods BD, Sladen RN. Perioperative considerations for the patient with asthma and bronchospasm. Br J Anaesth. 2009;103(supplemental):i57–65.

    Article  PubMed  Google Scholar 

  40. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.

    Article  CAS  PubMed  Google Scholar 

  41. Rajesh MC. Anaesthesia for children with bronchial asthma and respiratory infections. Indian J Anaesth. 2015;59(9):584–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Zachary CY, Evans R. Perioperative management for childhood asthma. Ann Allergy Asthma Immunol. 1996;77:468–72.

    Article  CAS  PubMed  Google Scholar 

  43. Liccardi G, Salzillo A, De Blasio F, D’Amato G. Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anesthesia and/or intravascular administration or radiographic contrast media. Curr Med Res Opin. 2009;25:1621–30.

    Article  PubMed  Google Scholar 

  44. von Ungern-Sternberg BS, Boda K, Chambers NA, et al. Risk assessment for respiratory complication in paediatric anesthesia: a prospective cohort study. Lancet. 2010;376:773–83.

    Article  Google Scholar 

  45. Tirumalasetty J, Grammer LC. Asthma, surgery, and general anesthesia: a review. J Asthma. 2006;43:251–4.

    Article  PubMed  Google Scholar 

  46. FW S, Beckman DB, Yarnold PA, Grammer LC. Low incidence of complications in asthmatic patients treated with preoperative corticosteroids. Allergy Asthma Proc. 2004;25(5):327–33.

    Google Scholar 

  47. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast research study group. Arch Intern Med. 1998;158(11):1213.

    Article  CAS  PubMed  Google Scholar 

  48. Young SL, Coulthard P, Wrzosek A, Supplemental A. Perioperative steroids for surgical patients with adrenal insufficiency. Cochrane Database Syst Rev. 2012;12:CD005367.

    Google Scholar 

  49. de Lange DW, Kars M. Perioperative glucocorticoid supplementation is not supported by evidence. Eur J Intern Med. 2008;19(6):461–7.

    Article  PubMed  CAS  Google Scholar 

  50. MacKenzie R, Goodman SM. Stress dose steroids: myths and perioperative medicine. Curr Rheumatol Rep. 2016;18:47.

    Article  PubMed  CAS  Google Scholar 

  51. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337(18):1285.

    Article  CAS  PubMed  Google Scholar 

  52. Chernow B, Alexander HR, Smallridge RC, Thompson WR, et al. Hormonal responses to graded surgical stress. Arch Intern Med. 1987;147(7):1273–8.

    Article  CAS  PubMed  Google Scholar 

  53. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727.

    Article  CAS  PubMed  Google Scholar 

  54. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinol Metab Clin North Am. 2003;32(2):367–83.

    Article  CAS  PubMed  Google Scholar 

  55. Ackerman GL, Nolsn CM. Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med. 1968;278(8):405.

    Article  CAS  PubMed  Google Scholar 

  56. Fauci AS. Alternate-day corticosteroid therapy. Am J Med. 1978;64(5):729.

    Article  CAS  PubMed  Google Scholar 

  57. LaRochelle GE, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic disease receiving low-dose prednisone. Am J Med. 1993;95(3):258–64.

    Article  PubMed  Google Scholar 

  58. Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet. 1967;2(7521):856–9.

    Article  CAS  PubMed  Google Scholar 

  59. Vann MA. Perioperative management of ambulatory surgical patients with diabetes mellitus. Curr Opin Anesthesiol. 2009;22:718–24.

    Article  Google Scholar 

  60. Joshi GP, Chung F, Vann MA, et al. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010;111(6):1378.

    Article  PubMed  Google Scholar 

  61. Dhataruya K, Levy N, Kilvert A, et al. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420–33.

    Article  CAS  Google Scholar 

  62. McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. JAMC. 2005;173(5):502–4.

    Google Scholar 

  63. Jendle J, Grunberger G, et al. Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program. Diabetes Metab Res Rev. 2016;32:776–90.

    Article  CAS  PubMed  Google Scholar 

  64. Hirsch IB, McGill JB. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care. 1990;13(9):980.

    Article  CAS  PubMed  Google Scholar 

  65. Peters A, Kerner W. Perioperative management of the diabetic patient. Exp Clin Endocrinol Diabetes. 1995;103(4):213.

    Article  CAS  PubMed  Google Scholar 

  66. Metchick LN, Petit WA Jr, Inzucchi SE, et al. Inpatient management of diabetes mellitus. Am J Med. 2002;113(4):317.

    Article  PubMed  Google Scholar 

  67. Marks JB. Perioperative management of diabetes. Am Fam Physician. 2003;67(1):93.

    PubMed  Google Scholar 

  68. Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient. South Med J. 2006;99(6):580.

    Article  PubMed  Google Scholar 

  69. Hoogwerf BJ. Perioperative management of diabetes mellitus: how should we act on evidence? Cleve Clin J Med. 2006;73(Suppl 1):S95.

    Article  PubMed  Google Scholar 

  70. MGH Insulin Comparison Chart. http://ww4.mgh.org/Physicians/Formulary%20Documents/Insulin%20Comparison%20Chart.pdf. Accessed on 28 Nov 16.

  71. Bennett-Guerrero E, Kramer DC, Schwinn DA. Effect of chronic and acute thyroid hormone reduction on perioperative outcome. Anesth Analg. 1997;85:30–6.

    CAS  PubMed  Google Scholar 

  72. Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter. Arch Intern Med. 2004;164:1675–9.

    Article  PubMed  Google Scholar 

  73. Vickers P, Garg KM, Arya R, Godha U, Mathur P, Jain S. The role of selective beta 1-blocker in the preoperative preparation of thyrotoxicosis: a comparative study with propranolol. Int Surg. 1990;75(3):179.

    CAS  PubMed  Google Scholar 

  74. Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendal FR. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001;344(20):1527.

    Article  CAS  PubMed  Google Scholar 

  75. Smart A, Gallagher J. Clinicians and women’s learning package on Sugammadex (Bridion) and hormonal contraceptives. Aust Nurs Midwifery J. 2015;22(9):52.

    PubMed  Google Scholar 

  76. Baron TH, Kamath PS, McBane RD. Management of Antithrombotic Therapy in patients undergoing invasive procedures. N Engl J Med. 2013;368(22):2113–24.

    Article  CAS  PubMed  Google Scholar 

  77. McBane RD, Wysokinski WE, Daniels PR, et al. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol. 2010;30:442–8.

    Article  CAS  PubMed  Google Scholar 

  78. Kleinman NS. Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation. Circulation. 2012;125:1967–70.

    Article  Google Scholar 

  79. Schulman S, Elbazi R, Zondag M, O’Donnell M. Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. Thromb J. 2008;16:15.

    Article  CAS  Google Scholar 

  80. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849–60.

    Article  PubMed  CAS  Google Scholar 

  81. Carmignani L, Picozzi S, Bozzini G, et al. Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: a meta-analysis. Transfus Apher Sci. 2011;45:275–80.

    Article  PubMed  Google Scholar 

  82. Devereaux PJ, Mrokbrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370(16):1494–503.

    Article  CAS  PubMed  Google Scholar 

  83. Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G. Platelet-active drugs: the relationship among dose, effectiveness, and side effects. Chest. 2001;119(1 suppl):39s.

    Article  CAS  PubMed  Google Scholar 

  84. Stone DH, Goodney PP, Schanzer A, Nolan BW, Adams JE, et al. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg. 2011;54(3):779–84.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Dweck MR, Cruden NL. Noncardiac surgery in patients with coronary artery stents. Arch Intern Med. 2012;172(14):1054–5.

    Article  PubMed  Google Scholar 

  86. Beattie WS, Warriner CB, Etches R, Badner NH, Parsons D, et al. The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgesic morphine regimen reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty. Anesth Analg. 1997;84(4):715.

    Article  CAS  PubMed  Google Scholar 

  87. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Juni P. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med. 2005;142(7):506.

    Article  CAS  PubMed  Google Scholar 

  89. BRIDGE: Study Investigators. Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure? Circulation. 2012;126:1630–9.

    Article  CAS  Google Scholar 

  90. Healy JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, RE-LY Investigators. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation. 2012;126(3):343.

    Article  CAS  Google Scholar 

  91. White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ration. Ann Intern Med. 1995;122(1):40.

    Article  CAS  PubMed  Google Scholar 

  92. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e326S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Huyse FJ, Touw DJ, van Schijndel RS, de Lange JJ, Slaets JP. Psychotropic drugs and the perioperative period: a proposal for a guidance in elective surgery. Psychosomatics. 2006;47(1):8.

    Article  CAS  PubMed  Google Scholar 

  94. Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011;183(16):1835.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Auerbach AD, Vittinghoff E, Maselli J, Pekow PS, Young JQ, Lindenauer PK. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med. 2013;173(12):1075–81.

    Article  CAS  PubMed  Google Scholar 

  96. Tully PJ, Cardinal T, Bennetts JS, Baker RA. Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery. Heart Lung Circ. 2012;21(4):206–14.

    Article  CAS  PubMed  Google Scholar 

  97. Xiong GL, Jiang CRM, Shaw LK, Smith PK, et al. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Clin Cardiol. 2010;33(6):E94–8.

    Article  PubMed  Google Scholar 

  98. Attri JP, Bala N, Chatrath V. Psychiatric patient and anaesthesia. Indian J Anaesth. 2012;56(1):8–13.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Stack CG, Rogers P, Linter SP. Monoamine oxidase inhibitors and anaesthesia. A review. Br J Anaseth. 1988;60(2):222.

    Article  CAS  Google Scholar 

  100. Peck T, Wong A, Norman E. Anaesthetic implications of psychoactive drugs. Continuing education in Anaesthesia, critical care and pain. Br J Anaesth. 2010;10(6):177–81.

    Google Scholar 

  101. Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20(7):763.

    Article  PubMed  Google Scholar 

  102. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Larsen KA, Kelly SE, Stern TA, Bode RH Jr, Price LL, Hunter DJ, Gulczynski D, et al. Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized controlled trial. Psychosomatics. 2010;51(5):409.

    Article  CAS  PubMed  Google Scholar 

  104. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med. 2012;40(3):731–9.

    Article  PubMed  CAS  Google Scholar 

  105. Muluk V, Cohn SL, and C Whinney. Perioperative medication management. UpToDate. 2016. Accessed on 3 Nov 2016.

    Google Scholar 

  106. Fischer SP, Schmiesing CA, Guta CG, Brock-Utne JG. General anesthesia and chronic amphetamine use: should the drug be stopped preoperatively? Anesth Analg. 2006;103(1):203.

    Article  PubMed  Google Scholar 

  107. Bryson EO. The perioperative management of patients maintained on medications used to manage addiction. Curr Opin Anesthesiol. 2014;27:359–64.

    Article  CAS  Google Scholar 

  108. Srivastava A, Kahan M. Methadone induction doses: are our current practices safe? J Addict Dis. 2006;25(3):5–13.

    Article  PubMed  Google Scholar 

  109. Shields LB, Hunsaker JC, Corey TS, et al. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52(6):1389–95.

    Article  PubMed  Google Scholar 

  110. Center for Substance Abuse Treatment (CSAT). Medication-assisted treatment for opioid addiction in opioid treatment programs. In:Treatment improvement protocol [TIP] series 43. HHS publication no. (SMA) 08–4214. Rockville, MD: CSAT, Substance Abuse and Mental Health Services Administration; 2008.

    Google Scholar 

  111. Modesto-Lowe V, Brooks D, Petry N. Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med. 2010;9:898.

    Google Scholar 

  112. Webster LR, Cochella S, Dasgupta N, et al. An analysis of root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12:S26–35.

    Article  PubMed  Google Scholar 

  113. Orman JS, Keating GM. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs. 2009;69(5):577–607.

    Article  CAS  PubMed  Google Scholar 

  114. Mastracci TM, Carli F, Finley RJ, Muccio S, Warner DO. Members of the evidence-based reviews in surgery group. Effect of postoperative smoking cessation interventions on postoperative complications. J Am Coll Surg. 2011;212(6):1094.

    Article  PubMed  Google Scholar 

  115. Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2010;7:CD002294.

    Google Scholar 

  116. Warner DO. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology. 2006;104(2):356.

    Article  PubMed  Google Scholar 

  117. Smetana GW, Lawrence VA, Cornell JE. American College of Physicians. Preoperative pulmonary risk stratification for noncardiac surgery: systematic review for the American college of physicians. Ann Intern Med. 2006;144(8):581.

    Article  PubMed  Google Scholar 

  118. Sousa G, Pinho C, Santos A, Abelha FJ. Postoperative delirium in patients with history of alcohol abuse. Rev Esp Anestesiol Reanim. 2017;64(4):214–22.

    Article  CAS  PubMed  Google Scholar 

  119. Hudetz JA, Iqbal Z, Gandhi SD, et al. Postoperative cognitive dysfunction in older patients with a history of alcohol abuse. Anesthesiology. 2007;106(3):423–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James Omlie D.D.S., M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Omlie, J., Herlich, A. (2018). Chronic Medications and Maxillofacial Surgery. In: Ferneini, E., Bennett, J. (eds) Perioperative Assessment of the Maxillofacial Surgery Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-58868-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58868-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58867-4

  • Online ISBN: 978-3-319-58868-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics